For 2025, Merck said it still expects sales of $64.1 billion to $65.6 billion, but it lowered its adjusted earnings per share ...

Merck lowered its full-year profit guidance and said tariffs would mean an extra $200 million in costs this year. The stock ...

On a per-share basis, the Rahway, New Jersey-based company said it had profit of $2.01. Earnings, adjusted for one-time gains and costs, came to $2.22 per share. The results exceeded Wall Street ...

Merck’s first-quarter net income increased as sales of its Keytruda cancer drug rose, but the Big Pharma company cut its 2025 ...

A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs (shareholders) alleged that they bought MRK stock at artificially inflated ...

Amid the worst U.S.-China trade clash in modern history, Michelle Xia thinks she has something Chinese that Americans will want. It isn’t a $3 T-shirt or an electronic gadget. It is a cancer ...

The global Latin America Advanced Wound Care Market, valued at US$285.9 million in 2024, is forecasted to grow at a robust CAGR of 9.8%, reaching US$312.8 million in 2025 and an impressive US$498.2 ...

Merck for Mothers' grant of half a million dollars will help expand the reach of Baby2Baby's initiative to combat the maternal health crisis across the country LOS ANGELES, April 10, 2025 ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Merck is paying $25 million upfront to tap into Cerevance's NETSseq transcriptomics technology, used to discover proteins that are either over- or under-expressed in disease states, and is also ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...